Literature DB >> 29538656

Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Michael H Parkinson1,2, Ana P Bartmann2, Lisa M S Clayton2, Suran Nethisinghe1, Rolph Pfundt3, J Paul Chapple4, Mary M Reilly1,2,5, Hadi Manji2, Nicholas J Wood1,2, Fion Bremner2, Paola Giunti1,2.   

Abstract

Autosomal recessive spastic ataxia of Charlevoix-Saguenay is a rare neurodegenerative disorder caused by mutations in the SACS gene. Thickened retinal nerve fibres visible on fundoscopy have previously been described in these patients; however, thickening of the retinal nerve fibre layer as demonstrated by optical coherence tomography appears to be a more sensitive and specific feature. To test this observation, we assessed 292 individuals (191 patients with ataxia and 101 control subjects) by peripapillary time-domain optical coherence tomography. The patients included 146 with a genetic diagnosis of ataxia (17 autosomal spastic ataxia of Charlevoix-Saguenay, 59 Friedreich's ataxia, 53 spinocerebellar ataxias, 17 other genetically confirmed ataxias) and 45 with cerebellar ataxia of unknown cause. The controls included 13 asymptomatic heterozygotes for SACS mutations and 88 unaffected controls. The cases with autosomal recessive spastic ataxia of Charlevoix-Saguenay included 11 previously unpublished SACS mutations, of which seven were nonsense and four missense mutations. Most patients were visually asymptomatic and had no previous history of ophthalmic complaints and normal or near normal visual test results. None had visual symptoms directly attributable to the retinal changes. Twelve of the 17 cases (70.6%) had thickened retinal nerve fibres visible on fundoscopy. All patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay had thickening of the peripapillary retinal nerve fibre layer on optical coherence tomography, whereas all the remaining cases and controls except one showed normal or reduced average peripapillary retinal nerve fibre layer thickness on optical coherence tomography. We propose a cut-off value of 119 µm in average peripapillary retinal nerve fibre layer thickness, which provides a sensitivity of 100% and specificity of 99.4% amongst patients affected with ataxia. This is the largest cohort of patients with this condition to undergo systematic evaluation by optical coherence tomography. This is a useful tool in identifying cases of autosomal recessive spastic ataxia of Charlevoix-Saguenay from other causes of ataxia. Visualization of thickened retinal fibres by direct fundoscopy is less sensitive. We therefore advocate the use of this technique in the assessment of possible cases of this condition.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29538656     DOI: 10.1093/brain/awy028

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  10 in total

1.  14th EUNOS Congress: PORTO, PORTUGAL, 16-19 JUNE 2019.

Authors: 
Journal:  Neuroophthalmology       Date:  2019-06-07

2.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

3.  Novel mutation in a patient with Charlevoix-Saguenay ataxia-a very rare disease with classical symptoms.

Authors:  Aleksandra Klimkowicz-Mrowiec; Anna Dziubek; Małgorzata Sado; Marek Karpiński
Journal:  Neurol Sci       Date:  2021-10-24       Impact factor: 3.307

4.  Clinical and molecular studies in two new cases of ARSACS.

Authors:  Ivana Ricca; Federica Morani; Giacomo Maria Bacci; Claudia Nesti; Roberto Caputo; Alessandra Tessa; Filippo Maria Santorelli
Journal:  Neurogenetics       Date:  2019-01-24       Impact factor: 2.660

5.  Absent Foveal Avascular Zone in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.

Authors:  Vivian Paraskevi Douglas; Konstantinos A A Douglas; John B Miller; Eric D Gaier
Journal:  J Neuroophthalmol       Date:  2021-06-01       Impact factor: 3.042

6.  Case Report: Expanding the Genetic and Phenotypic Spectrum of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.

Authors:  Parham Habibzadeh; Zahra Tabatabaei; Soroor Inaloo; Muhammad Mahdi Nashatizadeh; Matthis Synofzik; Vahid Reza Ostovan; Mohammad Ali Faghihi
Journal:  Front Genet       Date:  2020-12-22       Impact factor: 4.599

Review 7.  Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration.

Authors:  Jaya Bagaria; Eva Bagyinszky; Seong Soo A An
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

8.  Hsp90 Inhibition: A Promising Therapeutic Approach for ARSACS.

Authors:  Suran Nethisinghe; Rosella Abeti; Maheswaran Kesavan; W Christian Wigley; Paola Giunti
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

Review 9.  Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome.

Authors:  Marjolaine Tremblay; Laura Girard-Côté; Bernard Brais; Cynthia Gagnon
Journal:  Orphanet J Rare Dis       Date:  2022-10-01       Impact factor: 4.303

10.  Longitudinal Assessment Using Optical Coherence Tomography in Patients with Friedreich's Ataxia.

Authors:  Petya Bogdanova-Mihaylova; Helena Maria Plapp; Hongying Chen; Anne Early; Lorraine Cassidy; Richard A Walsh; Sinéad M Murphy
Journal:  Tomography       Date:  2021-12-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.